4
Changes in Ownership
Edgewise Therapeutics, Inc. Filed Acc 0001209191-21-023869
Director bought 15,625 shares at $16.00 ($250,000)
- Director acquired 3,473,543 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
ROOT JONATHAN D · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-30 | Conversion : show line 1 in the form | +3,473,543 | 3,473,543 | I | ||
| 2021-03-30 | Purchase : show line 2 in the form | +15,625 | $16.00 | $250,000 | 15,625 | D |
| Open-market purchases · 15,625 sh · avg $16.00 · $250,000 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-30 | Conversion : show line 3 in the form Series B-1 Preferred Stock | −1,651,607 | 0 | I |
| 2021-03-30 | Conversion : show line 4 in the form Series B-2 Preferred Stock | −1,366,707 | 0 | I |
| 2021-03-30 | Conversion : show line 5 in the form Series C Preferred Stock | −455,229 | 0 | I |
Loading xslF345X03/doc4.xml…